We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$68.3M
Cap. Flow
-$7.33M
Cap. Flow %
-0.62%
Top 10 Hldgs %
20.9%
Holding
1,162
New
74
Increased
183
Reduced
261
Closed
76

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$877K
2
CVS icon
CVS Health
CVS
+$822K
3
STZ icon
Constellation Brands
STZ
+$809K
4
TD icon
Toronto Dominion Bank
TD
+$719K
5
FDX icon
FedEx
FDX
+$704K

Top Sells

Rank Stock Value
1
USB.PRH icon
US Bancorp Series B Preferred Stock
USB.PRH
+$3.95M
2
GS.PRD icon
Goldman Sachs Group Inc Series D Preferred Stock
GS.PRD
+$2.24M
3
META icon
Meta Platforms (Facebook)
META
+$1.08M
4
XOM icon
ExxonMobil
XOM
+$815K
5
BNS icon
Scotiabank
BNS
+$719K

Sector Composition

Rank Sector Weight
1 Healthcare 13.61%
2 Financials 12.88%
3 Technology 12.78%
4 Industrials 11.93%
5 Consumer Discretionary 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIDD icon
701
Middleby
MIDD
$5.28B
$14K ﹤0.01%
109
– –
MTD icon
702
Mettler-Toledo International
MTD
$28.5B
$14K ﹤0.01%
23
– –
MTUM icon
703
iShares MSCI USA Momentum Factor ETF
MTUM
$26.3B
$14K ﹤0.01%
+118
New +$13.6K
NZF icon
704
Nuveen Municipal Credit Income Fund
NZF
$2.44B
$14K ﹤0.01%
961
– –
PINC
705
DELISTED
Premier
PINC
$14K ﹤0.01%
300
– –
SCHB icon
706
Schwab US Broad Market ETF
SCHB
$45.1B
$14K ﹤0.01%
1,170
– –
TEVA icon
707
Teva Pharmaceuticals
TEVA
$43.2B
$14K ﹤0.01%
652
– –
ULTA icon
708
Ulta Beauty
ULTA
$22.1B
$14K ﹤0.01%
48
– –
URI icon
709
United Rentals
URI
$69.8B
$14K ﹤0.01%
88
– –
AVNS
710
DELISTED
Avanos Medical
AVNS
$13K ﹤0.01%
183
-24
-12% -$1.54K
BWA icon
711
BorgWarner
BWA
$13.9B
$13K ﹤0.01%
354
+113
+47% +$4.44K
CABO icon
712
Cable One
CABO
$196M
$13K ﹤0.01%
15
– –
CII icon
713
BlackRock Enhanced Captial and Income Fund
CII
$1.02B
$13K ﹤0.01%
750
– –
EQNR icon
714
Equinor
EQNR
$95.9B
$13K ﹤0.01%
472
+72
+18% +$1.89K
ESPR
715
DELISTED
Esperion Therapeutics
ESPR
$13K ﹤0.01%
300
– –
KSS icon
716
Kohl's
KSS
$2.17B
$13K ﹤0.01%
171
– –
PLOW icon
717
Douglas Dynamics
PLOW
$986M
$13K ﹤0.01%
300
– –
SYF icon
718
Synchrony
SYF
$25.9B
$13K ﹤0.01%
409
– –
TDG icon
719
TransDigm Group
TDG
$68.5B
$13K ﹤0.01%
36
– –
VOT icon
720
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.2B
$13K ﹤0.01%
92
– –
WRK
721
DELISTED
WestRock Company
WRK
$13K ﹤0.01%
241
– –
PRSP
722
DELISTED
Perspecta Inc. Common Stock
PRSP
$13K ﹤0.01%
496
– –
AKAM icon
723
Akamai
AKAM
$17.9B
$12K ﹤0.01%
159
– –
APTV icon
724
Aptiv
APTV
$10.1B
$12K ﹤0.01%
147
– –
BIP icon
725
Brookfield Infrastructure Partners
BIP
$18.2B
$12K ﹤0.01%
504
– –
27 28
29
30 31

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Trust Company of Vermont's Q3 2018 Portfolio in Review

As of Q3 2018, Trust Company of Vermont held 1,162 positions worth $1.18B, up 6.1% from $1.12B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trust Company of Vermont's Q3 2018 filing shows 74 new, 183 increased, 261 reduced and 76 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 3,351 shares worth $895K. The largest sale was US Bancorp Series B Preferred Stock, an estimated $3.95M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

  • Trust Company of Vermont's largest Q3 2018 buy was Vanguard S&P 500 ETF: 3,351 shares worth $895K.
  • Trust Company of Vermont added most to CVS Health in Q3 2018, an estimated $822K increase.
  • Trust Company of Vermont's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.08M.
  • Trust Company of Vermont fully exited US Bancorp Series B Preferred Stock in Q3 2018, selling an estimated $3.95M.
  • Trust Company of Vermont's ten largest holdings make up 21% of its $1.18B portfolio in Q3 2018.
  • Trust Company of Vermont opened 74 new positions and closed 76 in Q3 2018.
  • Trust Company of Vermont's portfolio value rose 6.1% quarter-over-quarter to $1.18B.

Based on Trust Company of Vermont's 13F filing for Q3 2018, filed 26 Oct 2018.